{
    "nctId": "NCT05744518",
    "briefTitle": "Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI",
    "officialTitle": "Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast Dynamic Contrasted-Enhancement Magnetic Resonance Imaging",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Complete Pathologic Response (pCR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female;\n2. Age 18 years or older\u037e\n3. Diagnosis of invasive breast cancer by ultrasound guided biopsy\u037e\n\n3. Planed for receiving neoadjuvant chemotherapy (NAC) 4. Planned definitive breast surgery following completion of NAC.\n\nExclusion Criteria:\n\n1. Stage IV breast cancer;\n2. Previous ipsilateral breast cancer;\n3. Previous treatment (chemotherapy or radiation) to involved breast\u037e\n4. Medically unstable\u037e\n5. Pregnant or nursing.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}